Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Richard Greil (First author), Hubert Stein^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Department of Surgery

Research output: Contribution to journal › Editorial › peer-review

19 Citations (Web of Science)

Original language	English
Pages (from-to)	189-190
Journal	LANCET ONCOL
Volume	8
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(07)70053-0
Publication status	Published - 2007

Keywords

CHEMOTHERAPY
CHEMORADIOTHERAPY
CARCINOMA

Access to Document

10.1016/S1470-2045(07)70053-0

Cite this

@article{7f68046e53d74fca97638b773532f3ef,

title = "Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?",

keywords = "CHEMOTHERAPY, CHEMORADIOTHERAPY, CARCINOMA",

author = "Richard Greil and Hubert Stein",

year = "2007",

doi = "10.1016/S1470-2045(07)70053-0",

language = "English",

volume = "8",

pages = "189--190",

journal = "LANCET ONCOL",

issn = "1470-2045",

publisher = "Elsevier ",

number = "3",

}

TY - JOUR

T1 - Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

AU - Greil, Richard

AU - Stein, Hubert

PY - 2007

Y1 - 2007

KW - CHEMOTHERAPY

KW - CHEMORADIOTHERAPY

KW - CARCINOMA

U2 - 10.1016/S1470-2045(07)70053-0

DO - 10.1016/S1470-2045(07)70053-0

M3 - Editorial

C2 - 17329188

SN - 1470-2045

VL - 8

SP - 189

EP - 190

JO - LANCET ONCOL

JF - LANCET ONCOL

IS - 3

ER -